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the spread of tumor cells from pri-mary sites often occurs as associated 
cell collectives. in this form of invasion, 
the contribution of cells leading the way 
may differ from those that follow. by 
implication, proteins that regulate the 
actin cytoskeleton, a major driver of 
cell motility, may have different roles 
depending on whether they are in lead-
ing or following cells. the lim kinases 1 
and 2 (limK) phosphorylate and inacti-
vate the filamentous actin severing func-
tion of cofilin proteins. using sirna or 
pharmacological inhibitors, limK was 
found to be required in leading cells of 
collectively invading tumor cells, or in 
cancer-associated stromal fibroblasts, for 
effective extracellular matrix degradation 
that facilitates three-dimensional inva-
sion. the decreased extracellular matrix 
degrading activities were associated with 
an inability to form the stable filamen-
tous actin structures necessary to make 
matrix-degrading protrusive structures. 
however, limK was not required for cell 
motility or for path-following in associ-
ated collectives. these findings show 
that leading and following cells in col-
lective invasion have different properties 
and indicate that targeting the activities 
in leading cells is sufficient to signifi-
cantly inhibit tumor cell invasiveness.
The metastatic spread of tumor cells from 
primary to distal sites mounts the most 
significant challenge to the well-being 
of cancer patients.1 As a result, there is 
intense interest in understanding the 
underlying molecular mechanisms that 
drive the local invasion, dissemination 
and ultimately metastasis of cancer cells. 
In particular, a major objective sought by 
academic and industrial researchers is the 
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identification of potentially druggable tar-
gets that if inhibited would limit cancer 
spread without affecting normal cell and 
tissue functions. The actin cytoskeleton 
is the motor that powers cell motility, 
and numerous proteins contribute to the 
dynamic flux of cytoskeletal structures 
that facilitate movement.2 Therefore, pro-
teins that regulate the actin cytoskeleton 
are attractive as targets for inhibiting can-
cer spread. Given that relatively straight-
forward enzymatic assays and focussed 
chemical libraries have been developed 
to help kinase inhibitor discovery, we 
decided that attractive candidate targets 
for potential anti-metastatic agents were 
the LIM kinase 1 and 2 (LIMK).
LIM kinases act as network hubs in sig-
naling pathways that communicate from 
Rho GTPase proteins to the regulation 
of the actin cytoskeleton.3 Their primary 
vocation appears to be the phosphoryla-
tion and inactivation of the filamentous-
actin (F-actin) severing cofilin family 
proteins,4 although there is some evidence 
that LIMK may also have cofilin-indepen-
dent functions.5 When unphosphorylated, 
cofilin proteins sever F-actin within aged 
regions in which ATP hydrolysis to ADP 
has induced a conformational change. As 
a result, activation of LIMK through the 
phosphorylation of a Threonine residue 
within the activation loop by upstream 
kinases including ROCK, PAK and 
MRCK leads to increased F-actin stabil-
ity,3 while LIMK inhibition would be 
expected to have the opposite effect and 
decrease F-actin stability.
In order to examine the contribution 
of LIMK to tumor cell invasiveness, we 
decided to adopt a two-pronged approach 
using siRNA-mediated knockdown and 
a potent, selective and non-cytotoxic 
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LIM kinases in one color cell line while 
transfecting the other color cell line with 
control siRNA revealed that LIMK was 
required for path-generation, since the 
corresponding color cell was under-repre-
sented in the leading position. However, 
the identity of the cell immediately after 
the leading cell was equally split between 
the LIMK-targeted and the control 
siRNA-transfected colors, indicating that 
path-following abilities were unaffected 
by LIMK inhibition. These results were 
again consistent with the conclusion that 
LIMK activity was required for matrix 
remodeling that facilitates path-genera-
tion but not for cell motility that enables 
cells to follow paths.
Using a variety of two-dimensional 
and three-dimensional models, we found 
that knocking down or inhibiting LIMK 
reduced matrix degradation and the 
secretion of active matrix metalloprote-
ase activity. These effects were associ-
ated with an inability to form protrusive 
matrix-degrading invadapodia structures, 
which previous research has shown to be 
dependent on F-actin stabilization.19-21 
Not only did LIMK inhibition result in 
an overall decrease in F-actin staining 
intensity, but fluorescence recovery after 
photobleaching (FRAP) experiments 
revealed that F-actin stability was signifi-
cantly reduced. As a result, we concluded 
that at least one way that LIMK inhibi-
tion impaired the ability of cells to lead 
collective invasion was through reduced 
F-actin stability, which directly impacted 
upon the ability of cells to degrade matrix. 
In support of this conclusion, direct 
knockdown of matrix metalloprotease 
9 also reduced the ability of cells to be 
path-generating leading cells. However, 
it cannot be excluded that an additional 
factor might be a reduction in the delivery 
of matrix metalloproteases from the Golgi 
to the plasma membrane or extracellular 
surroundings, given that a role for cofilin 
in cargo sorting at the trans-Golgi net-
work has been reported.22
We also examined whether inhibit-
ing LIMK would affect the ability of 
cells to physically remodel the extra-
cellular matrix by measuring collagen 
contraction. One possibility is that the 
decreased F-actin stability resulting from 
LIMK inhibition would lower internal 
As a result, cells may have different roles 
in the invading collective; for example 
path-generating cells would require extra-
cellular matrix remodeling activities ver-
sus path-following cells which would only 
require the ability to move through these 
paths. Upon reflection, this observation 
makes a great deal of sense, the acquisition 
of all the properties required for a tumor 
cell to break away from the primary mass 
and become independently invasive is 
actually relatively improbable. As long as 
the occasional tumor cell is able to be a 
trailblazer, a proportionally greater num-
ber of cells will probably have acquired the 
smaller subset of properties that enable 
them to be path-followers. An additional 
possibility is that non-tumor stromal cells 
may be selected for, or re-programmed 
through the secretion by tumor cells of 
paracrine factors such as TGFβ,16 to pro-
vide the path-generating activity. Again, 
this would enable the more probably 
acquired properties required for path-
following to be manifested in collective 
tumor cell invasion.
As mentioned above, many of the 
invasive cell lines commonly used in 
three-dimensional assays invade as indi-
viduals. Although the MDA MB 231 
breast cancer cell line is often described 
as being mesenchymal-like,17 it retains 
sufficient epithelial characteristics that 
it invades three-dimensional matrigel as 
collective strands.18 In order to delineate 
the contribution of LIM kinases to three-
dimensional collective invasion, we cre-
ated two pools of cells stably expressing 
either membrane-targeted red or green 
fluorescent proteins (RFP or GFP) by 
drug selection followed by enrichment 
for fluorescence intensity by live cell sort-
ing. When the two colored pools were 
mixed, the overall invasion was compa-
rable to the original parental cell line, 
and image analysis revealed that there 
were equal representations of RFP or 
GFP expressing cells at the lead position 
of each strand. One of the most challeng-
ing aspects of these experiments was the 
confocal imaging and three-dimensional 
reconstructions required to identify each 
strand’s leading cell. However, the effort 
was rewarded as this system allowed us to 
query whether specific proteins were nec-
essary in leading cells. Knocking down 
LIMK inhibitor that had been developed 
by Bristol-Myers Squibb.6 Using three-
dimensional invasion assays we found 
that LIMK inhibition by either method 
resulted in significantly decreased inva-
sion.7 Interestingly, although many 
reports in the literature have implicated a 
specific role for either LIMK1 or LIMK2 
in various processes,8-11 we found that 
the selective knockdown of either pro-
tein alone had only small effects that 
were additive when both were targeted or 
inhibited simultaneously. Similar results 
were reported for individual versus com-
bined knockdown of LIMK1 and LIMK2 
in a zebrafish xenograft model of pancre-
atic cancer metastasis.12 Given the role 
of LIMK in regulating F-actin and the 
significant effects on decreasing three-
dimensional invasion, we were surprised 
that both siRNA-mediated knockdown 
and LIMK inhibition did not affect cell 
motility using a modified scratch would 
assay or when intrinsic motility on 
fibroblast-derived matrix was measured. 
The discrepancies between the effects of 
LIMK inhibition on three-dimensional 
invasion through matrix protein and two-
dimensional motility suggested that the 
most likely explanation was an effect on 
the ability of cells to create a path through 
the mechanically-resistant protein envi-
ronment through which they could travel.
Although the importance of studying 
cell invasion through three-dimensional 
environments has become widely accepted 
as being more relevant to the in vivo situ-
ation than simple two-dimensional motil-
ity models,13 it is often the behavior of 
highly-invasive tumor cells that invade as 
individuals that is examined. However, 
the ability of tumor cells to escape from 
the primary tumor mass and locally 
invade their surroundings as individuals 
is actually rare and somewhat unusual. 
Instead, epithelial cancer cells often 
invade collectively in strands, sheets and 
clusters without necessarily losing their 
cell-cell adhesions.14 The cell collective 
may remain in contact with the tumor, 
or may break free and move away from 
the primary site. In this form of invasion, 
the leading cells create paths of reduced 
physical resistance through a combina-
tion of protease activity and mechanical 
force to remodel the extracellular matrix.15 
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invasion when LIMK was inhibited 
(fig. 1). This observation suggests that 
collective invasion may indeed be a reflec-
tion of relatively less effective invasive 
abilities than individual cell invasion. 
An additional possibility is that LIMK 
inhibition promotes the restoration of 
cell-cell adhesions that favor collective 
over individual invasion.
The major challenge for the future 
will be providing the “proof of principle” 
evidence in clinical studies which dem-
onstrates that specifically targeting the 
processes that contribute to invasion and 
metastasis translates into patient ben-
efit. Given the tremendous plasticity and 
adaptability of tumor cells when encoun-
tering changes in their environment, this 
may prove to be an unachievable goal. 
However, since it has been suggested that 
metastasis plays a significant role in the 
mortality of 90% of cancer sufferers,1 
even incremental successes could have 
substantial impacts upon the quality of 
life and survival of numerous cancer suf-
ferers. Time will tell whether the effects 
of inhibiting LIMK on cancer cell inva-
sion that have been reported by us and 
others will lead to eventual cancer thera-
pies, but the potential for positive clinical 
outcomes is a strong motivator for contin-
ued research.
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actomyosin contractile force and cellular 
tension, leading to a reduction in external 
pulling force on matrix protein fibrils. We 
did indeed observe that knocking down 
or inhibiting LIMK reduced collagen 
contraction by cancer-associated fibro-
blasts (CAFs).23 Given that inhibiting 
LIMK also reduced matrix degradation, 
we also wondered whether proteolysis 
actually facilitated contraction. When 
MT1-MMP, which is the major matrix 
metalloprotease in CAFs,7 was knocked 
down there was a significant inhibition 
in collagen contraction. Therefore, we 
concluded one way LIMK activity con-
tributes to matrix remodeling is to facili-
tate the proteolysis of cross-linked matrix 
proteins that would otherwise be too rigid 
for contraction to occur. It remains a pos-
sibility that an additional contribution 
of LIMK activity is to promote F-actin 
stability which contributes to actomyosin 
contractile force generation. There cur-
rently is heated debate about whether the 
extent of matrix protein cross-linking in 
three-dimensional model systems is an 
accurate reflection of the in vivo situa-
tion,13,24 with implications for the inter-
pretation of studies in which the motility 
modes of individual tumor cells has been 
examined. However, it seems likely that 
the dogmatic division of three-dimen-
sional motility modes into two distinct 
categories as either requiring matrix deg-
radation or force-mediated remodeling25 
may be somewhat artificial since force-
mediated remodeling actually appears 
to be dependent on some level of matrix 
degradation. Further research will reveal 
the extent of the interdependence of these 
two matrix remodeling activities.
An interesting and important concept 
that has emerged from recent studies is 
the remarkable plasticity of cancer cell 
motility modes.26 Although some cells 
seem to prefer to force their way through 
three-dimensional matrix while others 
tend to use proteolysis to generate their 
paths, tumor cells will adopt the most 
favorable mode when meeting an impasse. 
Similarly, cells that are capable of invad-
ing as individual cells may switch to col-
lective invasion if circumstances dictate. 
We observed that the individual three-
dimensional matrix invasion by BE colon 
carcinoma cells27 converted to collective 
Figure 1. LIMK inhibition converts the invasion mode of BE colon carcinoma cells from individual 
to collective. Optical slices of three dimensional matrigel invasion assays of propidium iodide 
stained BE colon carcinoma cells revealed that their typical individual invasion mode (left) was 
converted to invasion of collective strands by LIMK inhibitor treatment (right). These findings sug-
gest that individual tumor cell invasion has higher demands for the activities that contribute to 
invasiveness (e.g., remodeling of the extracellular matrix, reduced cell-cell contacts) than collec-
tive invasion, in which tumor cells may remain in contact with each other and matrix remodeling 
need only be performed by leading cells. Scale bar = 100 μm.
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